Pablo C. Okhuysen

Infectious Disease

1515 Holcombe Blvd Unit 1460
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Bezlotoxumab for the prevention of recurrent Clostridioides difficile infection for patients with cancer.

Bezlotoxumab for the prevention of recurrent Clostridioides difficile infection for patients with cancer.

Journal: Annals of gastroenterology

Published: May 31, 2025

Ten Practical Tips for a Successful Presentation at an Infectious Disease Clinical Case Conference.

Ten Practical Tips for a Successful Presentation at an Infectious Disease Clinical Case Conference.

Journal: Open forum infectious diseases

Published: April 14, 2025

Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis.

Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis.

Journal: Cancer medicine

Published: April 03, 2025

The impact of cancer-related diarrhea on changes in cancer therapy.

The impact of cancer-related diarrhea on changes in cancer therapy.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: February 07, 2024

Tryptophan Metabolites And Their Predicted Microbial Sources In Fecal Samples From Healthy Individuals.

Tryptophan Metabolites And Their Predicted Microbial Sources In Fecal Samples From Healthy Individuals.

Journal: bioRxiv : the preprint server for biology

Published: January 08, 2024

Increased Prevalence of Clostridioides difficile Infection Among Pediatric Oncology Patients: Risk Factors for Infection and Complications.

Increased Prevalence of Clostridioides difficile Infection Among Pediatric Oncology Patients: Risk Factors for Infection and Complications.

Journal: The Pediatric infectious disease journal

Published: December 22, 2023

Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease.

Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease.

Journal: Cell host & microbe

Published: December 19, 2023

A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.

A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 02, 2023

Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial.

Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial.

Journal: EBioMedicine

Published: August 20, 2023

Functional Genomics of Gastrointestinal Escherichia coli Isolated from Patients with Cancer and Diarrhea.

Functional Genomics of Gastrointestinal Escherichia coli Isolated from Patients with Cancer and Diarrhea.

Journal: bioRxiv : the preprint server for biology

Published: July 03, 2023

Bacteroides ovatus alleviates dysbiotic microbiota-induced intestinal graft-versus-host disease.

Bacteroides ovatus alleviates dysbiotic microbiota-induced intestinal graft-versus-host disease.

Journal: Research square

Published: February 13, 2023

Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment.

Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment.

Journal: Science translational medicine

Published: November 16, 2022

Showing 1-12 of 53

Last Updated: 09/26/2026